~~<i id='B96E98073F'><strike id='B96E98073F'><tt id='B96E98073F'><pre id='B96E98073F'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：comprehensive 2025-09-30 15:36:23 Page View：6

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump pressured former Arizona governor to overturn 2020 election results: Sources
Next article： Affirmative action in medical school literally saved lives

explore

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Russians and Belarusians back at Wimbledon as war in Ukraine continues

VictoriaAzarenkaofBelarusplaysareturntoChina'sYuanYueduringthefirstroundwomen'ssinglesmatchondayoneo

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Bird flu reported in person exposed to presumably infected cattle

RodrigoAbd/APTexashealthofficialsreportedMondaythatanindividualwhohadbeenincontactwithcattlehascontr